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Abstract
The influence of socioeconomic inequalities in pancreatic cancer patients and especially its
effect in patients who had a resection is not known. Hospital type in which resection is per-
formed might also influence outcome. Patients diagnosed with pancreatic cancer from 1989
to 2011 (n = 34,757) were selected from the population-based Netherlands Cancer Registry.
Postal code was used to determine SES. Multivariable survival analyses using Cox regres-
sion were conducted to discriminate independent risk factors for death. Patients living in a
high SES neighborhood more often underwent resection and more often were operated in a
university hospital. After adjustment for clinicopathological factors, risk of dying was
increased independently for patients with intermediate and low SES compared to patients
with high SES. After resection, no survival difference was found among patients in the three
SES groups. However, survival was better for patients treated in university hospitals com-
pared to patients treated in non-university hospitals. Low SES was an independent risk fac-
tor for poor survival in patients with pancreatic cancer. SES was not an adverse risk factor
after resection. Resection in non-university hospitals was associated with a worse
prognosis.
Introduction
Despite advances in knowledge concerning risk factor reduction and improvements in early
detection and treatment of several cancers, socioeconomic inequalities persist in incidence
and survival[1–5]. Low socioeconomic status (SES) has proven to be an important risk factor
for developing upper aerodigestive tract cancer[6]. It is also a risk factor for poor survival in
patients with cancer of lung[7], stomach[8], and breast[9], as well as hepatocellular carcinoma
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[10]. Furthermore it is associated with late presentation and recurrence in colorectal cancer
[11].
Like in other countries, mortality rates from pancreatic cancer in the Netherlands remain
high. The 1-year survival is 18% and only four percent of the patients is alive after five years
(period 1989–2010). The incidence of pancreatic carcinoma is slightly increasing in the Neth-
erlands; 8.9/100.000 persons in 1989 and 9.4/100.000 persons in 2015(ESR: European standard
Ratio)[12]. Pancreatic resection is the only potentially curative treatment, but only a minority
of the patients with pancreatic cancer are eligible for surgery.
Some studies showed that pancreatic cancer patients of low SES neighborhoods were less
likely to receive surgical resection[5], chemotherapy[13], or radiotherapy[2], and had signifi-
cantly higher perioperative and long-term mortality rates than patients with higher SES[2,14].
This may be the result of poorer access to health care for people with low SES, which results in
delayed diagnosis and inferior treatment. Although we would not expect this to be the case in
the Netherlands, as the obligatory insurance coverage should prevent inequalities in health
care access, a higher resection rate was found in a study about stomach cancer in the Nether-
lands[8]. We therefore aimed to evaluate the patients who underwent pancreatic resection.
Since there is a known relationship between hospital volume and mortality after resection of
pancreatic cancer[15,16], we investigated whether patients from higher SES groups were more
often referred to high-volume university hospitals for treatment. To test these hypotheses we
performed a nationwide study in the Netherlands using the population-based database from
the Netherlands Cancer Registry.
Methods
Cancer registration
All patients diagnosed with pancreatic carcinoma between January 1st, 1989 and December 31,
2011 (n = 34,757) were selected from the population-based Netherlands Cancer Registry,
which contains data on all patients newly diagnosed with cancer in the Netherlands. The can-
cer registry obtains notifications from PALGA (Pathologisch Anatomisch Landelijk Geauto-
matiseerd Archief), the nationwide network and registry of histopathology and cytopathology
in the Netherlands. Additional sources are the national registry of hospital discharge, which in
general accounts for another eight percent of new cases, and–in a minority of cases- radiother-
apy institutions. Information on patient characteristics and tumor characteristics such as sub-
site (International Classification of Diseases for Oncology (ICD-O-3)[17], histology, stage
(Tumor lymph Node Metastasis (TNM) classification[18]), and grade, are obtained routinely
from the medical records. In patients who underwent resection (14% of the total study group)
stage was based on pathological TNM (I,II,III,IV). In the 86% unresectable patients, the clinical
stage was based on clinical TNM or the one-dimensional Extent of Disease was used. These
were combined into one variable with 4 categories; 1) ‘local’ = tumor irrespective of size but
confined to the pancreas, classification T1 or T2 (TNM 6th and 7th edition); 2) ‘beyond pan-
creas’ = tumor extension beyond pancreas, classification T2 (according to TNM classification
4th and 5th edition), or T3 or T4, or positive lymph nodes; 3) metastasized disease, M1; and 4)
unknown stage. The site of the tumor in the pancreas is reported as head (ICD-O C25.0), not
head (ICD-O C25.1–78) and “not otherwise specified/overlapping” (C25.8–9).
The type of hospital in which the pancreatic resection was performed was categorized into:
(1) university hospitals (n = 8), (2) non-university teaching hospitals (n = 46) and (3) non-uni-
versity non-teaching hospitals (n = 46; classification in 2010). A teaching hospital is defined as
any hospital which provides medical training to surgical residents to become board-certified
Impact of Socioeconomic Status on Outcome in Pancreatic Cancer
PLOS ONE | DOI:10.1371/journal.pone.0166449 November 10, 2016 2 / 10
Funding: The authors received no specific funding
for this work.
Competing Interests: The authors have declared
that no competing interests exist.
surgeons. If the hospital of surgery was not registered, the hospital of diagnosis was assumed to
be the hospital of surgery.
The quality of the data in the Netherlands Cancer Registry is high, due to thorough training
of the administrators and computerized consistency checks at regional and national levels and
completeness is estimated to be at least 95%[19]. Follow-up of vital status of all patients was
calculated as the time from the date of diagnosis to the date of death or to January 1st, 2013.
The information on vital status was initially obtained from municipal registries and from 1995
onwards from the nationwide municipal population registries network.
Socioeconomic status (SES) scores
Postal code at time of diagnosis was used to determine SES. SES scores are available for each of
the 4,002 four-digit postal code neighborhood in the Netherlands. SES scores were calculated
in 2006, and these formed the basis for the current analysis. The mean number of inhabitants
was 4080 per postal code in 2006. SES scores are provided by the Netherlands Institute for
Social Research (Sociaal Cultureel Planbureau) and based on the following items which were
collected per six-digit postal code: 1) mean annual income per household, 2) the percentage of
households with a low income and 3) the percentage of households with a low education[20].
SES was divided into three groups based on the delivered rank numbers: low (1st-3rd deciles,
n = 10,294), intermediate (4th-7th, n = 13,775) and high (8th-10th, n = 10,274) SES.
Statistical analyses
Associations between SES of neighborhood, stage of disease, localization of the tumor, histo-
logical grade of the tumor and treatment were analyzed by Chi-square analysis and calculation
of 95% confidence intervals (95%CI). Association between SES and age at diagnosis were ana-
lyzed by one-way Anova analysis.
Overall 5-year survival rates were calculated. Cox’ regression models were used to compute
multivariable rates (Hazard Ratio = HR, forward procedure) and 95% confidence intervals
(95%CI). Statistical analysis was performed with Stata version 12.
Results
In the period 1989–2011 34,757 patients were diagnosed with pancreatic cancer in the Nether-
lands. The mean age at diagnosis was 70 years (range 15 to 101 years). Most patients were diag-
nosed with metastatic disease (45%).
Table 1 shows differences in patient and tumor characteristics between different SES
groups. The low SES group is characterised by more females, slightly older age, and less fre-
quent resection of the tumor. Of note, 10% of the patients living in high SES neighborhoods
underwent resection, whereas in the low SES neighborhoods this was 9% (p = 0.006, Table 1).
Patients with higher SES were treated with adjuvant chemotherapy more often than patients
with lower SES (22% versus 18%, p = 0.02).
The highest volume of operated patients was observed in university hospitals; eight hospi-
tals performed 1,198 resections (= 35% (34–37% 95%CI)), as compared to 1,350 resections
(= 40% (38–41% 95%CI)) in 46 non-university teaching hospitals and 833 resections (= 25%
(23–26% 95% CI)) in 41 non-university non-teaching hospitals.
Table 2 summarizes the prognostic factors in all patients presenting with pancreatic cancer.
Favorable prognostic factors in multivariable analysis were a medium and high SES and resect-
able tumors, while adverse prognostic factors were older age, non-head tumor localization,
tumor differentiation other than well differentiated, and TNM stage I.
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Table 3 shows the prognostic factors in 3,381 patients who underwent a resection. On mul-
tivariable analysis adverse prognostic factors were: operation in other than university hospitals
and poorly differentiated tumors. Patients with TNM stage I disease had a more favorable
prognosis compared to patients with other stages of disease. Of note, whereas SES was a risk
factor in the whole group of pancreatic cancer patients, this was not the case anymore in the
group of patients who underwent a resection (univariable analysis SES Low (reference) HR: 1;
SES Medium HR1.04 (95% CI 0.9–1.1; SES High HR 0.98 (95% CI 0.89–1.07).
Discussion
The main findings of this nationwide study in patients with pancreatic cancer are that low SES
is an independent risk factor for poor survival, whereas in pancreatic cancer patients who
underwent resection, SES is not a risk factor. These results confirm findings in other studies in
which pancreatic cancer patients with lower SES tend to have worse survival and are less likely
to receive adequate treatment (Table 4). In the two series reporting on patients who underwent
resection the results are contradictory: the Lim paper [21] (n = 396 patients) describes lower
survival in the low SES group, whereas in the Kuhn paper [22] (n = 117 patients) no effect was
found.
Among the variables which are significantly different in the three SES groups–gender, age,
tumor localization, differentiation, stage and resection—we consider only resection a clinical
relevant variable, because this has a major impact on outcome. In this study, patients with low
SES less often underwent resection and had therefore more often an unknown stage than
Table 1. Distribution of individual characteristics of patients with pancreatic cancer in the Nether-




% 95% CI % 95% CI % 95% CI p-value
Gender Male 48 47–49 50 49–51 50 49–51 0.02
Female 52 51–53 50 49–51 50 49–51
Age <30 0.1 0.0–0.1 0.1 0.0–0.1 0.1 0.0–0.1 0.006
30–44 1.9 1.6–2.2 2.0 1.7–2.2 2.2 2.0–2.5
45–59 16 15–17 17 16–17 18 –17-18
60–74 43 42–44 44 43–45 44 43–45
75+ 39 38–40 37 36–38 37 36–38
Tumorlocalization Head 68 67–69 69 68–69 68 67–68 0.009
Non-head 18 18–19 18 17–19 20 19–21
Overlapping lesion/nos 13 13–14 14 13–14 13 12–13
Differentiation Well 3.06 2.7–3.4 3.2 2.9–3.5 2.9 2.5–3.2 0.015
Moderate 10 10–11 11 10–11 11 11–12
Poor 10 10–11 11 11–12 11 28–30
Undifferentiated 0.7 0.60.9 0.7 0.5–0.8 0.7 0.5–0.8
Unknown 76 75–77 74 74–75 74 73–75
Stage local 14 14–15 14 13–14 13 12–13 0.02
Beyond pancreas 28 27–29 28 28–29 29 28–30
metastatic 45 44–46 45 44–46 45 44–46
Unknown 13 12–13 13 12–13 14 13–15
Resection No 91 90–10 90 90–91 90 89–90 0.006
Yes 9 9–10 10 9–10 10 10–11
doi:10.1371/journal.pone.0166449.t001
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patients with high SES. After adjustment for confounding factors, SES remained an indepen-
dent prognostic variable. However, in patients with resectable tumors, SES was no longer a rel-
evant variable for survival. This was also found in a case series of 117 patients in Germany in
which the SES was obtained from individual patients[22].
We found that patients with higher SES were more often operated in a university hospital.
Furthermore, resection for pancreatic cancer in a non-university (teaching or non-teaching)
hospital was associated with an increased risk of dying as compared to resection in a university
hospital. University hospitals have higher volumes of pancreatic resections, because of referral
patterns for this type of surgery. The lower volumes in most of the non-university hospitals
might be a part of the explanation for the worse outcome, because low volume is a well-known
risk factor for poor outcome in various surgical procedures including pancreatic resections
[15,16,24]. For example, a study in a population of patients with periampullary cancer in the
Southern part of the Netherlands also revealed that patients who underwent resection in a uni-
versity hospital had a better three-month survival as compared to patients treated in a low vol-
ume hospital (performing less than five resections a year) in the region[26]. However, apart
from differences in patient selection of patient referral, other explanations might be differences
in staff-to-patient ratios, financial resources, more easy access to specialized diagnostic and
treatment possibilities, and higher qualified intensive care units[34].
Table 2. Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreatic cancer patients in the Netherlands,
period 1989–2011 (n = 34,757).
Variables Univariable Multivariable
% HR 95% CI HR 95% CI
SES Low 30 1 Reference 1 Reference
Medium 40 0.96 094–0.99 0.96 0.94–0.99
High 30 0.92 0.90–0.95 0.93 0.90–0.95
Age 70(median) 1.0 1.0–1.0 1.02 1.01–1.02
Gender Men 49 1 Reference 1 Reference
Women 51 0.99 0.98–1.02 0.96 0.94–0.98
Localization Head 68 1 Reference 1 Reference
Non-head 19 1.3 1.2–1.3 1.1 1.07–1.13
NOS/Overlapping lesion 13 1.5 1.4–1.5 1.20 1.16–1.24
Differentiation Well 3 1 Reference 1 Reference
Moderate 11 1.1 1.1–1.2 1. 1.13–1.30
Poor 11 1.7 1.6–1.8 1.5 1.43–1.64
Undifferentiated 1 2.9 2.5–3.4 1.95 1.69–2.25
Unknown 75 1.9 1.8–2.0 1.21 1.43–1.29
Stage local 14 1 Reference 1 Reference
Beyond pancreas 28 1.0 0.9–1.0 1203 1.15–1.24
metastatic 45 2.4 2.3–2.5 2.29 2.21–2.37
unknown 5 1.5 1.5–1.6 1.31 1.26–1.37
Resection No 90 1 Reference 1 Reference
Yes 10 0.3 0.3–0.3 0.43 0.41–0.45
Adjuvant chemotherapy No 80 1 Reference Not included in multivariable
analysis
Yes 20 0.3 0.3–0.3
CI: Confidence Interval.
doi:10.1371/journal.pone.0166449.t002
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Health disparities originate in the complex interplay of patient, health-care provider and
institutional factors. Major determinants of survival are tumor characteristics[35], and the
presence of disseminated disease[36]. Other factors like psycho-social and bio-behavioral
influences[37], environmental influences, and income-related lifestyle factors may play a role
in cancer pathogenesis[5,38,39]. Patients of lower SES probably have more associated comor-
bidity[40] and additionally may lack the knowledge to comprehend the complex details of
their diagnosis, may not be well informed about the possible improved outcome at university
hospitals and may lack social support and structure[2]. Data from a study in the United States
showed that patients with pancreatic carcinoma with lower SES were treated more frequently
in low volume hospitals, compared with patients with higher SES. However, when patients
from lower SES were treated in a high volume and or teaching hospital, they still had increased
perioperative mortality and shorter median survival[2]. In a recently published paper on
patients after pancreaticoduodenectomy, we could demonstrate that in the Netherlands
30-day mortality was 4.6% and 90-day mortality 7.8%. In that paper, describing only patients
who underwent resection, SES was not predicting peri-operative death, neither 30-day mortal-
ity nor 90-day mortality. Thus, we extrapolate that postoperative mortality and SES are not
predictors of cancer survival.[41]
In our study, patients from higher SES neighborhoods were more likely to receive adjuvant
chemotherapy. We cannot exclude the likelihood that patients who received adjuvant therapy
were less ill and thus judged to be better candidates for such treatment. Treatment with adju-
vant chemotherapy has been introduced in the Netherlands in 2007 after publication of the
CONKO-001 study[42]. Therefore only limited data are available precluding a multivariable
analysis with adjuvant chemotherapy. Possibly this chemotherapy contributes to better sur-
vival in the latest period.
Table 3. Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreatic cancer patients who underwent resection
in the Netherlands, period 2005–2011. (n = 3,381).
Univariable Multivariable
% of patients HR 95% CI HR 95% CI
Type of hospital University 35 1 Reference 1 Reference
Non-university, teaching 40 1.2 1.1–1.3 1.2 1.13–1.33
Non-university, non teaching 25 1.3 1.-149 1.5 1.33–1.61
Age 65(median) 1.01 1.0–1.02 1.01 1.00–1.02
Gender Men 54 1 Reference 1 Reference
Women 46 0.95 0.9–1.0 1.00 0.93–1.08
Differentiation Well 11 1 Reference 1 Reference
Moderate 44 1.3 1.2–1.5 1.3 1.12–1.44
Poor 29 1.8 1.6–2.0 1.7 1.5–2.0
Undifferentiated 0.3 1.3 0.6–2.6 0.9 0.5–1.9
Unknown 17 1.0 0.9–1.2 1.1 0.96–1.27
Stage (TNM) I 26 1 Reference 1 Reference
II 44 1.5 1.9–2.8 1.5 1.35–1.63
III 22 1.9 1.9–3.3 1.8 1.66–2.05
IV 5 2.5 2.1–5.0 2.5 2.14–2.99
Unknown 2 1.0 0.8–1.3 1.1 0.86–1.42
Adjuvant chemotherapy No 80 1 Reference 1 Reference
Yes 20 0.7 0.6–0.8 0.7 0.64–0.78
doi:10.1371/journal.pone.0166449.t003
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In 40% of patients the presumed diagnosis of pancreatic cancer could not be proven by his-
tology or cytology, because most of the patients with pancreatic cancer are unresectable, which
also explains that around 75% of the patients in each SES group has an unknown histological
grade.



















PaC - None - - - Higher pancreatic mortality in
urban residents
Janes[24] 1996 16,942 PaC 8.8 - # # # More resections and lower
postoperative mortality if
treated in high volume center
or in teaching hospital
Krzyzanowska
[25]
2003 1,696 LA-PaC - - - # # More cancer directed therapy
if treated in teaching hospital
Lim[21] 2003 396 PaC Only patients who
underwent resection
# # # # Better survival if surgery in
teaching hospital
Van Oost[26] 2006 1,130 PaC 11 - - - - Low SES: less referred to
university hospital
Cress[14] 2006 10,612 PaC 15.8 #(UV) # - -
Zell[27] 2007 24,735 70.1%
PaC
11.8 # (UV) # # #
Le[28] 2008 15,296 66.6%
PaC 0.3%
IPMN
12 None* # # #
Kuhn[22] 2009 117 PaC Only patients who
underwent resection
None - - -
Cheung[2] 2010 16,104 PaC 18.8† # # # # Low SES: younger at
diagnosis
Seyedin[29] 2012 5,908 PaC No data - # - -
Cheung[30] 2013 58,747 PaC 16.2 - # - -
Bernards[13] 2014 1,494 PaC** - - - # -
Enewold[31] 2015 977 PaC 22.1 None None - - Low SES: more frequently
associated with no treatment
Wolfson[32] 2015 2,317 PaC - - - - - Low SES: less patients




2015 245 PaC 29 # - - -
Shapiro[5] 2015 17,530 PaC 45.4 - # - - Lower SES: worse stage at
presentation
Present Series 34,757 PaC 14.9 # # # -





*: only studied for IPMN tumors;
†: patients treated surgically (not only resection);
NCICCC: National Cancer Institute Comprehensive Cancer Center;
R
: patients treated in a NCICCC had better survival and were presented with lower stage of disease;
**: only patients with metastatic disease.
doi:10.1371/journal.pone.0166449.t004
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Limitations of our study are the way of measuring SES and the lack of information on spe-
cific referral patterns in relation to SES. We used an ecological measure of SES, which was
assigned to each individual patient according to the postal code of residence at the time of
diagnosis. Theoretically it is possible that individual people are misclassified and that infer-
ences at the area level do not directly transfer to individuals. In practice, validation studies,
however have found that an area-based measure of SES is a good indicator of SES for individu-
als. Another limitation is the absence of information on comorbidity. Comorbidity may be a
factor underlying lower survival in cancer patients with low SES[40].
In conclusion, this study demonstrated that SES was an independent prognostic factor in a
nationwide-study of a large cohort of pancreatic cancer patients in the Netherlands. Perform-
ing a pancreatic resection is the most important prognostic factor and is more frequently per-
formed in patients with high SES versus patients with low SES. Remarkably, in patients who
underwent resection, SES is no longer a risk factor. Resection in university hospitals is associ-
ated with the highest chance of survival. With the knowledge of the differences in treatment
between patients with different SES, specialists treating patients with pancreatic cancer should
make effort to explain the different treatment options to all patients groups clearly and afford
referral to a center for pancreatic surgery.
Acknowledgments
The authors thank the registration team of the Netherlands Comprehensive Cancer Organisa-
tion (IKNL) for the collection of data for the Netherlands Cancer Registry (NCR) as well as
IKNL staff for scientific advice.
Author Contributions
Conceptualization: KPDJ.
Data curation: MAVDA LGMVDG.






Writing – original draft: MHGVR.
Writing – review & editing: MHGVR MAVDA LGMVDG KPDJ.
References
1. Niu X, Pawlish KS, Roche LM. Cancer survival disparities by race/ethnicity and socioeconomic status in
New Jersey. J Health Care Poor Underserved. 2010; 21: 144–160. doi: 10.1353/hpu.0.0263 PMID:
20173261
2. Cheung MC, Yang R, Byrne MM, Solorzano CC, Nakeeb A, Koniaris LG. Are patients of low socioeco-
nomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer. 2010; 116:
723–733. doi: 10.1002/cncr.24758 PMID: 19998350
3. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic sta-
tus on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology,
Impact of Socioeconomic Status on Outcome in Pancreatic Cancer
PLOS ONE | DOI:10.1371/journal.pone.0166449 November 10, 2016 8 / 10
and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009; 20: 417–435. doi:
10.1007/s10552-008-9256-0 PMID: 19002764
4. Murphy MM, Tseng JF, Shah SA. Disparities in cancer care: an operative perspective. Surgery. 2010;
147: 733–737. doi: 10.1016/j.surg.2009.10.050 PMID: 19962161
5. Shapiro M, Chen Q, Huang Q, Boosalis VA, Yoon CH, Saund MS, et al. Associations of Socioeconomic
Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer. JAMA
Surg. 2015.
6. Conway DI, McKinney PA, McMahon AD, Ahrens W, Schmeisser N, Benhamou S, et al. Socioeco-
nomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer. 2010;
46: 588–598. doi: 10.1016/j.ejca.2009.09.028 PMID: 19857956
7. Yang R, Cheung MC, Byrne MM, Huang Y, Nguyen D, Lally BE, et al. Do racial or socioeconomic dis-
parities exist in lung cancer treatment? Cancer. 2010; 116: 2437–2447. doi: 10.1002/cncr.24986 PMID:
20209616
8. Siemerink EJ, Hospers GA, Mulder NH, Siesling S, van der Aa MA. Disparities in survival of stomach
cancer among different socioeconomic groups in North-East Netherlands. Cancer Epidemiol. 2011; 35:
413–416. doi: 10.1016/j.canep.2011.02.015 PMID: 21470931
9. Aziz Z, Iqbal J, Akram M, Anderson BO. Worsened oncologic outcomes for women of lower socio-eco-
nomic status (SES) treated for locally advanced breast cancer (LABC) in Pakistan. Breast. 2010; 19:
38–43. doi: 10.1016/j.breast.2009.10.005 PMID: 19892552
10. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, et al. Race, ethnicity, and socioeco-
nomic status influence the survival of patients with hepatocellular carcinoma in the United States. Can-
cer. 2010; 116: 1367–1377. doi: 10.1002/cncr.24817 PMID: 20101732
11. Bowman KC, Tabrizian P, Telem DA, Boudourakis L, Divino CM. Health disparity in complicated colo-
rectal cancer. Am Surg. 2010; 76: 164–167. PMID: 20336893
12. http://www.cijfersoverkanker.nl?language=en, Accessed September 2016
13. Bernards N, Haj Mohammad N, Creemers GJ, de Hingh IH, van Laarhoven HW, Lemmens VE. Ten
weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic
cancer in the south of the Netherlands. Acta Oncol. 2015; 54: 403–410. doi: 10.3109/0284186X.2014.
953257 PMID: 25263080
14. Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pan-
creas: a population-based study (United States). Cancer Causes Control. 2006; 17: 403–409. doi: 10.
1007/s10552-005-0539-4 PMID: 16596292
15. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk
surgery. N Engl J Med. 2011; 364: 2128–2137. doi: 10.1056/NEJMsa1010705 PMID: 21631325
16. de Wilde RF, Besselink MG, van der Tweel I, de Hingh IH, van Eijck CH, Dejong CH, et al. Impact of
nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg. 2012; 99: 404–
410. doi: 10.1002/bjs.8664 PMID: 22237731
17. Wittekind C, Greene F, Hutter R, editors. International Classification of Diseases for Oncology. Berlin:
UICC; 2005.
18. Sobin L, Hoppener P, editors. TNM Atlas. New York: UICC; Wiley-Liss; 2002.
19. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer regis-
tration in Limburg, The Netherlands. Int J Epidemiol. 1993; 22: 369–376. PMID: 8359950
20. Knol FA. From high to low; from low to high: the development of social status of neighbourhoods
between 1971–1995 (In Dutch). 1998.
21. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarci-
noma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003; 237: 74–85. doi:
10.1097/01.SLA.0000041266.10047.38 PMID: 12496533
22. Kuhn Y, Koscielny A, Glowka T, Hirner A, Kalff JC, Standop J. Postresection survival outcomes of pan-
creatic cancer according to demographic factors and socio-economic status. Eur J Surg Oncol. 2010;
36: 496–500. doi: 10.1016/j.ejso.2009.08.006 PMID: 19748206
23. Blot WJ, Fraumeni JF Jr, Stone BJ. Geographic correlates of pancreas cancer in the United States.
Cancer. 1978; 42: 373–380. PMID: 667808
24. Janes RH Jr, Niederhuber JE, Chmiel JS, Winchester DP, Ocwieja KC, Karnell JH, et al. National pat-
terns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg. 1996;
223: 261–272. PMID: 8604906
25. Krzyzanowska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real
world: population-based practices and effectiveness. J Clin Oncol. 2003; 21: 3409–3414. doi: 10.1200/
JCO.2003.03.007 PMID: 12972517
Impact of Socioeconomic Status on Outcome in Pancreatic Cancer
PLOS ONE | DOI:10.1371/journal.pone.0166449 November 10, 2016 9 / 10
26. van Oost FJ, Luiten EJ, van de Poll-Franse LV, Coebergh JW, van den Eijnden-van Raaij AJ. Outcome
of surgical treatment of pancreatic, peri-ampullary and ampullary cancer diagnosed in the south of The
Netherlands: a cancer registry based study. Eur J Surg Oncol. 2006; 32: 548–552. doi: 10.1016/j.ejso.
2006.01.019 PMID: 16569495
27. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and
survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;
16: 546–552. doi: 10.1158/1055-9965.EPI-06-0893 PMID: 17372250
28. Le H, Ziogas A, Rhee JM, Lee JG, Lipkin SM, Zell JA. A population-based, descriptive analysis of malig-
nant intraductal papillary mucinous neoplasms of the pancreas. Cancer Epidemiol Biomarkers Prev.
2008; 17: 2737–2741. doi: 10.1158/1055-9965.EPI-08-0417 PMID: 18843017
29. Seyedin S, Luu C, Stabile BE, Lee B. Effect of socioeconomic status on surgery for pancreatic adeno-
carcinoma. Am Surg. 2012; 78: 1128–1131. PMID: 23025956
30. Cheung R. Racial and social economic factors impact on the cause specific survival of pancreatic can-
cer: a SEER survey. Asian Pac J Cancer Prev. 2013; 14: 159–163. PMID: 23534717
31. Enewold L, Harlan LC, Tucker T, McKenzie S. Pancreatic cancer in the USA: persistence of undertreat-
ment and poor outcome. J Gastrointest Cancer. 2015; 46: 9–20. doi: 10.1007/s12029-014-9668-x
PMID: 25403828
32. Wolfson JA, Sun CL, Wyatt LP, Hurria A, Bhatia S. Impact of care at comprehensive cancer centers on
outcome: Results from a population-based study. Cancer. 2015; 121: 3885–3893. doi: 10.1002/cncr.
29576 PMID: 26218755
33. Markossian TW, O’Neal CM, Senkowski C. Geographic disparities in pancreatic cancer survival in a
southeastern safety-net academic medical center. Aust J Rural Health. 2015.
34. Shahian DM, Nordberg P, Meyer GS, Blanchfield BB, Mort EA, Torchiana DF, et al. Contemporary per-
formance of U.S. teaching and nonteaching hospitals. Acad Med. 2012; 87: 701–708. doi: 10.1097/
ACM.0b013e318253676a PMID: 22534588
35. van Roest MH, Gouw AS, Peeters PM, Porte RJ, Slooff MJ, Fidler V, et al. Results of pancreaticoduode-
nectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic
factor than tumor localization. Ann Surg. 2008; 248: 97–103. doi: 10.1097/SLA.0b013e31817b6609
PMID: 18580212
36. Effenberger KE, Schroeder C, Eulenburg C, Reeh M, Tachezy M, Riethdorf S, et al. Disseminated
tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. Int
J Cancer. 2012; 131: E475–83. doi: 10.1002/ijc.26439 PMID: 21932421
37. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of
bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6: 240–
248. doi: 10.1038/nrc1820 PMID: 16498446
38. McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for
cancer in low- and middle-income countries. Ann Oncol. 2011; 22: 2349–2357. doi: 10.1093/annonc/
mdq763 PMID: 21378201
39. Nilsen TI, Vatten LJ. A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-
Trondelag, Norway. Cancer Causes Control. 2000; 11: 645–652. PMID: 10977109
40. Louwman WJ, Aarts MJ, Houterman S, van Lenthe FJ, Coebergh JW, Janssen-Heijnen ML. A 50%
higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic
status. Br J Cancer. 2010; 103: 1742–1748. doi: 10.1038/sj.bjc.6605949 PMID: 20978508
41. van der Geest LG, Besselink MG, van Gestel YR, Busch OR, de Hingh IH, de Jong KP, et al. Pancreatic
cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A popula-
tion-based study in the Netherlands. Acta Oncol. 2015: 1–8.
42. Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, et al. Adjuvant chemotherapy
with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the
CONKO-001 randomized trial. JAMA. 2013; 310: 1473–1481. doi: 10.1001/jama.2013.279201 PMID:
24104372
Impact of Socioeconomic Status on Outcome in Pancreatic Cancer
PLOS ONE | DOI:10.1371/journal.pone.0166449 November 10, 2016 10 / 10
